Center-Authored Papers

Filters: Author is Erba, Harry P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
O'Donnell MR, Appelbaum FR, Coutre SE, Damon LE, Erba HP, Foran J, Lancet J, Maness LJ, Marcucci G, Maslak PG et al..  2008.  Acute myeloid leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(10):962-93.
2009
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
2010
Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, Erba HP, Slovak ML, Chen I-M, Willman CL, Kopecky KJ et al..  2010.  Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.. British journal of haematology. 148(1):48-58. Abstract
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M et al..  2010.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(4):549-55. Abstract
2013
Petersdorf SH, Kopecky KJ, Slovak M, Willman C, Nevill T, Brandwein J, Larson RA, Erba HP, Stiff PJ, Stuart RK et al..  2013.  A phase III study of gemtuzumab ozogamicin during induction and post-consolidation therapy in younger patients with acute myeloid leukemia.. Blood. Abstract
Erba HP, Othus M, Walter RB, Kirschbaum MH, Tallman MS, Larson RA, Slovak ML, Kopecky KJ, Gundacker HM, Appelbaum FR.  2013.  Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432.. Leukemia research. Abstract
Nand S, Othus M, Godwin JE, Willman CL, Norwood TH, Howard DS, Coutre SE, Erba HP, Appelbaum FR.  2013.  A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia.. Blood. 122(20):3432-3439. Abstract
Adenine Nucleotides
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M et al..  2010.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(4):549-55. Abstract
Adolescent
Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW et al..  2003.  Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(18):3512-9. Abstract
Adult
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J et al..  2009.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW et al..  2003.  Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(18):3512-9. Abstract
Aged
Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW et al..  2003.  Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(18):3512-9. Abstract
Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, Erba HP, Slovak ML, Chen I-M, Willman CL, Kopecky KJ et al..  2010.  Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.. British journal of haematology. 148(1):48-58. Abstract
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M et al..  2010.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(4):549-55. Abstract
Aged, 80 and over
Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW et al..  2003.  Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(18):3512-9. Abstract
Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, Erba HP, Slovak ML, Chen I-M, Willman CL, Kopecky KJ et al..  2010.  Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.. British journal of haematology. 148(1):48-58. Abstract
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M et al..  2010.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(4):549-55. Abstract
Antineoplastic Agents
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M et al..  2010.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(4):549-55. Abstract
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J et al..  2009.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
Crawford J, Althaus B, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP et al..  2007.  Myeloid growth factors. Clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 5(2):188-202.
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
Antineoplastic Combined Chemotherapy Protocols
Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW et al..  2003.  Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(18):3512-9. Abstract
Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, Erba HP, Slovak ML, Chen I-M, Willman CL, Kopecky KJ et al..  2010.  Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.. British journal of haematology. 148(1):48-58. Abstract
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J et al..  2009.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
Arabinonucleosides
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M et al..  2010.  Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(4):549-55. Abstract